Our Colorectal Cancer Canada’s Conferences

Clinical Trials Conferences 2024

This seminal pan-cancer conference continues to inform clinical trial networks, researchers, industry, and academic trial sponsors, HTA agencies, Health Canada, and national and international cancer patient groups to mention a few. Also, we highlight the work we do through our patient centered approach to cancer clinical trials working group (PACT).

Over the course of the past several years, we have made considerable progress in fostering patient and patient group partnerships among researchers and stakeholders engaged in cancer clinical trials and their engagement in the clinical trial continuum.

Our objectives for this year’s Conference include the following:

  • To showcase Canada as fertile ground for Clinical Trials
  • To educate and update on the good work and investments underway that will accelerate the clinical trial landscape in Canada over the new 2 to 3 years
  • To discuss where we are winning/advancing in Canada and where/what are the key barriers that must be addressed

Clinical trials are a vital step in the development of new treatments for colorectal cancer patients, and an opportunity for patients to have access to certain treatments earlier than otherwise possible. However, the number of cancer patients enrolled in clinical trials in Canada has for the past few years hovered between two and six percent, despite regular andrecurring interest from patients. Low participation can sink trials, delaying the approval of potentially life-saving drugs. Recognizing this important gap in Canada, CCC has hosted seven annual clinical trials conferences to bring relevant stakeholders together. The goal is to develop a Canadian clinical trials transformation initiative that includes the patient voice in the process.

Access the recordings from past conferences below.